Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and...
markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 17, 2024 12:38pm
RE:RE:RE:No update yet - why?!
" $4-5 million a year over the next 15 years would translate into $60-75M in revenue " If those numbers impress you, that would explain a lot.
(116)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 17, 2024 11:59am
RE:RE:No update yet - why?!
Interesting perspective. There is a need to distinguish who bought the licencing and global nature and structure of the agreement. Some critical details are not available to us like the royalty rate
...more
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:52pm
RE:RE:No update yet - why?!
1067 wouldn't be a "marginal" product if howie had the balls to sell it into the multi-billion dollar skin-lightening market. Trying to be politically correct has cost the company
...more
(2152)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 16, 2024 8:52pm
RE:No update yet - why?!
Don't believe co. BS that Abbvie deal will make co. profitable. Assume 1067 is a marginal product. Hope that 1326 is the big winner.
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 7:03pm
RE:RE:No update yet - why?!
If AbbVie doesn't do anything this year, it may be time to give up on this one.
(85)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jan 16, 2024 6:02pm
RE:No update yet - why?!
AbbVie assisted in the clinical trial and bought exclusive worldwide rights so I'm confident a company as sophisticated as Allergan will be moving forward with incorporating the SBM compound into
...more
(71)
•••
forhandlaren
X
View Profile
View Bullboard History
Post by
forhandlaren
on Jan 16, 2024 5:25pm
No update yet - why?!
I find it interesting that the web site still notify a future investor presentation update. So will there be additional news in the near future? I would suggest AbbVie product launch. After all, it
...more
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jan 16, 2024 4:25pm
Some of us may die before Howie ever delivers,
But others might just live long enough for this decades-long pain to be relieved. If they ever get their act together, there might just be some money to be made. I have a feeling that the lowly
...more
(44)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jan 16, 2024 3:47pm
RE:RE:RE:RE:What's this?
Howard is the largest shareholder from Sirona followed by Geraldine. Why should they only offer special gains to new investors like private equity firms? Sirona laboratories is a 100% subsidiary from
...more
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 12:39pm
RE:RE:RE:What's this?
I am honest, a foreign concept to you apparently.
(116)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 16, 2024 11:21am
RE:RE:What's this?
Yeesh, that is a grand leap. But nice try. how could they pay me at my rates - they don't have that much money. The way you go hot and cold every second moment over the past week, and in the past
...more
(33)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Jan 16, 2024 11:08am
RE:RE:RE:RE:SBM falls after that news?
I am sure the offer will not be only for the private equity investor. It will be for the Investor and howie & friends & family. But definetly not for all shareholder.
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:36am
RE:RE:RE:SBM falls after that news?
" I am personally not fussed here. It looks like there is more to the story around strategic investment that needs clarity, and whenever they get that figured out, we will likely go up again. JMO
...more
(1630)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 16, 2024 10:31am
RE:What's this?
Well biorun, you seem to be on the company payroll, so don't you have the answers?
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >